Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP studyAndré Willasch, Adriana Balduzzi, Amir Ali Hamidieh et al.|Bone Marrow Transplantation|2020Cited by 61
Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trendsNicolás Novitzky, Helen Baldomero, Mahmoud Aljurf et al.|Bone Marrow Transplantation|2018Cited by 43
Outcomes of patients undergoing allogeneic haematopoietic stem cell transplantation for congenital amegakaryocytic thrombocytopenia; a study on behalf of the PDWP of the EBMTClémence Aldebert, Selim Corbacioglu, Mony Fahd et al.|Bone Marrow Transplantation|2024Cited by 3
Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP StudyAndré Willasch, Peter Bader, Christina Peters et al.|Blood|2017Cited by 2
Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP studyAndré Willasch, Adriana Balduzzi, Christina Peters et al.|Bone Marrow Transplantation|2021Cited by 1